Sophie Gilbert
Download PDF
Sophie Gilbert
Use the future to build the present
Sophie Gilbert
Comment
Stakeholder Type
5.5SyntheticBiology5.4Science ofthe Originsof Life5.3FutureEconomics5.2Future ofEducation5.1ComplexSystemsScience4.4Democracy-affirming Technologies4.1Science-basedDiplomacy4.2Advances inScience Diplomacy4.3Digital Technologiesand Conflict3.7InfectiousDiseases3.6Solar RadiationModification3.5OceanStewardship3.4SpaceResources3.3Future FoodSystems3.2WorldSimulation3.1Decarbonisation2.6FutureTherapeutics2.5Organoids2.4ConsciousnessAugmentation2.3RadicalHealthExtension2.2HumanApplicationsof GeneticEngineering2.1CognitiveEnhancement1.6CollectiveIntelligence1.5AugmentedReality1.4BiologicalComputing1.3Brain-inspiredComputing1.2QuantumTechnologies1.1AdvancedAIHIGHEST ANTICIPATIONPOTENTIAL
5.5SyntheticBiology5.4Science ofthe Originsof Life5.3FutureEconomics5.2Future ofEducation5.1ComplexSystemsScience4.4Democracy-affirming Technologies4.1Science-basedDiplomacy4.2Advances inScience Diplomacy4.3Digital Technologiesand Conflict3.7InfectiousDiseases3.6Solar RadiationModification3.5OceanStewardship3.4SpaceResources3.3Future FoodSystems3.2WorldSimulation3.1Decarbonisation2.6FutureTherapeutics2.5Organoids2.4ConsciousnessAugmentation2.3RadicalHealthExtension2.2HumanApplicationsof GeneticEngineering2.1CognitiveEnhancement1.6CollectiveIntelligence1.5AugmentedReality1.4BiologicalComputing1.3Brain-inspiredComputing1.2QuantumTechnologies1.1AdvancedAIHIGHEST ANTICIPATIONPOTENTIAL

Profile:

Sophie Gilbert

Program LeadGESDA
    Sophie will be joining GESDA in June 2023 as the Program Lead for the Science Breakthrough Radar. Sophie obtained her PhD in biochemistry at the University of Oxford, before going on to study how environmental factors affect stem cell development at Imperial College London, later focusing on neurodevelopment at University College London. In 2019, she joined the Wellcome Trust, an independent charitable foundation, where she managed a multimillion pound portfolio of clinical and biomedical research, and Wellcome's investment in the UK’s flagship biomedical institute, the Francis Crick Institute.